US Broker Ratings

DexCom, Inc. (DXCM) Stock Analysis: Strong Buy Ratings Signal Potential Upside

DexCom, Inc. (NASDAQ: DXCM), a leader in the healthcare sector with a focus on medical devices, has been making significant strides in the continuous glucose monitoring..

IQVIA Holdings, Inc. (IQV): Analyst Consensus Reveals 36% Upside Potential for Healthcare Giant

Investors with an eye on the healthcare sector should consider the promising outlook for IQVIA Holdings, Inc. (NYSE: IQV), a leader in the diagnostics and research..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: A 30.72% Upside Potential Beckons Healthcare Investors

Intuitive Surgical, Inc. (NASDAQ: ISRG) has long been a trailblazer in the healthcare sector, especially within the niche of minimally invasive surgical systems. With its flagship..

Boston Scientific Corporation (BSX) Stock Analysis: 44% Potential Upside Signals Promising Investment Opportunity

For investors eyeing opportunities in the healthcare sector, Boston Scientific Corporation (NYSE: BSX) stands out with its robust market presence and promising potential upside. With a..

Novo Nordisk A/S (NVO) Stock Analysis: Exploring Growth Potential Amid Robust Revenue Gains

Investors eyeing opportunities in the healthcare sector should pay close attention to Novo Nordisk A/S (NVO), a Danish pharmaceutical giant with a commanding presence in diabetes..

Merck & Company, Inc. (MRK) Stock Analysis: Healthcare Giant’s 5.99% Upside Potential Captivates Investors

Merck & Company, Inc. (NYSE: MRK) stands as a formidable name in the global healthcare sector, showcasing a robust market capitalization of $302.33 billion. As one..

Regeneron Pharmaceuticals, Inc. (REGN): Analyst Ratings Signal Strong Buy with 30% Upside Potential

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), a titan in the biotechnology industry, has been capturing the attention of investors with a promising 30.43% potential upside. With its..

ResMed Inc. (RMD) Stock Analysis: Robust Growth Potential Amidst Healthcare Innovations

ResMed Inc. (NYSE: RMD), a leader in the healthcare sector, has been making significant strides in the medical instruments and supplies industry. With a market capitalization..

McKesson Corporation (MCK) Stock Analysis: Exploring a 23.97% Potential Upside and Solid Growth Prospects

Investors looking to diversify their portfolios with a robust player in the healthcare sector might find McKesson Corporation (NYSE: MCK) a compelling choice. With a commanding..

Novartis AG (NVS) Stock Analysis: Strong ROE and Strategic Focus Positioning for Growth

Novartis AG (NYSE: NVS), a leading player in the healthcare sector, specifically within the drug manufacturing industry, has once again caught the eye of investors with..

AbbVie Inc. (ABBV) Stock Analysis: Unraveling a 17% Potential Upside Amid Robust Buy Ratings

AbbVie Inc. (NYSE: ABBV), a titan in the healthcare sector specializing in drug manufacturing, has captured investor attention with a notable 17.24% potential upside. The biopharmaceutical..

Inspire Medical Systems, Inc. (INSP): Investor Outlook Highlights 33% Potential Upside

Inspire Medical Systems, Inc. (NYSE: INSP) is a noteworthy player in the healthcare sector, specifically within the medical devices industry. Headquartered in Golden Valley, Minnesota, Inspire..

Corcept Therapeutics Inc. (CORT) Stock Analysis: Exploring a 40.15% Potential Upside for Biotech Investors

Corcept Therapeutics Incorporated (NASDAQ: CORT) is attracting attention from investors with its focus on developing innovative treatments for severe endocrinologic, oncologic, metabolic, and neurologic disorders. With..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: Exploring a Promising 103% Upside Potential

Telix Pharmaceuticals Limited (ASX: TLX), a prominent player in the biotechnology sector, is gaining attention for its innovative approach to developing therapeutic and diagnostic radiopharmaceuticals. With..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: A Strong Buy with 10.83% Upside Potential

Lantheus Holdings, Inc. (NASDAQ: LNTH) stands as a notable player within the healthcare sector, specifically in the niche of specialty and generic drug manufacturing. With a..

Viatris Inc. (VTRS) Stock Analysis: Exploring a 6.19% Potential Upside in the Healthcare Sector

Viatris Inc. (NASDAQ: VTRS), a prominent player in the healthcare sector, operates in the specialized and generic drug manufacturing industry. With a market capitalization of $19.19..

Soleno Therapeutics, Inc. (SLNO) Stock Report: A Biotech Player with Steady ROE and Strategic Focus on Rare Diseases

Soleno Therapeutics, Inc. (NASDAQ: SLNO) stands out in the biotechnology sector with its strategic focus on treating rare diseases. With a market capitalization of $2.76 billion,..

Bio-Techne Corp (TECH) Stock Analysis: Unlocking a 41.84% Upside Potential in Healthcare Innovation

Bio-Techne Corporation (NASDAQ: TECH), a pioneering entity in the biotechnology arena, offers investors a fascinating opportunity with a significant potential upside of 41.84%. As a key..

Henry Schein, Inc. (HSIC) Stock Analysis: Exploring a 19.93% Potential Upside in Medical Distribution

Henry Schein, Inc. (NASDAQ: HSIC), a titan in the medical distribution sector, stands as a compelling choice for investors looking to tap into the healthcare industry...

Cytokinetics, Incorporated (CYTK): Investor Outlook with a 38% Upside Potential

Cytokinetics, Incorporated (NASDAQ: CYTK) stands at the forefront of the biotechnology sector, capturing investor attention with its innovative approach to treating muscle-related diseases. Headquartered in South..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds